Goro Nakayama

Nagoya University — Japan

Medicine · Health Sciences

44h-index5.9kcitations337works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(80), Pancreatic and Hepatic Oncology Research(58), Colorectal Cancer Treatments and Studies(58), Esophageal Cancer Research and Treatment(36), Cancer Treatment and Pharmacology(35)

Publications337 total

Bony pelvic resection is a risk factor for pelvic abscess after total pelvic exenteration for pelvic malignancies
Surgery Today·2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study
European Journal of Cancer·2025Open Access
Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis
Clinical & Translational Oncology·2025
Cholinergic Receptor Nicotinic Beta 2 Subunit Promotes the Peritoneal Disseminating Metastasis of Colorectal Cancer
Cancers·2025Open Access
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (Study rindo)
2025Open Access
High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
Anticancer Research·2025
The role of CST2 in the pathogenesis and prognosis of esophageal squamous cell carcinoma
Clinical & Translational Oncology·2025· 1 cited
Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer Patients
Anticancer Research·2025Open Access
Efficacy and safety of postoperative adjuvant chemotherapy with oxaliplatin for elderly patients: results from the CCOG-1302 study
International Journal of Clinical Oncology·2025Open Access
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).
Journal of Clinical Oncology·2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)
Cancers·2025· 6 citedOpen Access
Factors Affecting the Prognosis after Primary Tumor Resection for Patients with Metastatic Colorectal Cancer with Synchronous Peritoneal Metastasis: A Multi-center, Prospective, Observational Study
Journal of the Anus Rectum and Colon·2025· 1 citedOpen Access
Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases
Annals of Gastroenterological Surgery·2025· 1 citedOpen Access
<i>FAM32A</i>Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer
Cancer Genomics & Proteomics·2024· 1 citedOpen Access
Genome-wide microRNA Analysis Identified<i>miR-210-3p</i>Over-expression in Pancreatic Cancer Tissues as a Predictor of their Local Invasiveness
Anticancer Research·2024Open Access
77P Chronologic improvement in survival of first-line oxaliplatin based chemotherapy + targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database
Annals of Oncology·2024Open Access
Prognostic Impact of<i>CDKN2A</i>Mutations Associated With Smoking and Drinking History in Japanese Digestive Cancers
Anticancer Research·2024· 1 cited
ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma
Annals of Surgical Oncology·2024
Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways
Gastric Cancer·2024· 10 citedOpen Access
Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma
Annals of Surgical Oncology·2024· 6 cited
page 1 of 17Next →

Frequent Co-authors

Yasuhiro Kodera(49), Michitaka Fujiwara(46), Masahiko Koike(45), Suguru Yamada(41), Tsutomu Fujii(35), Hiroyuki Sugimoto(33), Chie Tanaka(29), Mitsuro Kanda(25), Daisuke Kobayashi(24), Shuji Nomoto(18), Hideki Takami(17), Naoki Iwata(16), Masamichi Hayashi(15), Mitsuro Kanda(13), Dai Shimizu(11), Akimasa Nakao(10), Yukiko Niwa(7), Ryoji Hashimoto(7), Kenta Murotani(6), Hisaharu Oya(6)